November 15, 2016
SAN FRANCISCO, CA. – Riptide Bioscience, Inc., today announced that it has won the Gold Award for Excellence at the 2016 Military Health Systems Research Symposium (MHSRS).
Riptide Bioscience Announces Cooperative Research and Development Agreement with the National Cancer Institute
October 3, 2016
SAN FRANCISCO, CA. – Henry Lopez, Executive Vice President of Riptide Bioscience, Inc., today announced the execution of a Cooperative Research and Development Agreement (NCI CRADA #03045) with the National Cancer Institute (NCI), part of the National Institutes of Health.
January 10, 2016
SAN FRANCISCO, CA. – Dr. George R. Martin, President of Riptide Bioscience, delivered an invited presentation to the American Association for Cancer Research (AACR) Special Conference on "The Function of Tumor Microenvironment in Cancer Progression," held in San Diego, California, on January 7 - 10, 2016.
October 9, 2015
WASHINGTON D.C. – U.S. Rep. Mike Thompson (CA-5) today announced a $1.5 million Defense Department grant for Riptide Bioscience, Inc. Riptide Bioscience is based in Vallejo on Mare Island.
October 1, 2014
SAN FRANCISCO, CA. – Charles Garvin, CEO of Riptide Bioscience, Inc., announced Riptide's initiation of work under a $222,179 Small Business Innovation Research federal grant. The grant, from the National Eye Institute (NEI), will go towards a research project titled Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.
Previous page < Additional articles >